Tag: TVT 2019

Edwards PASCAL™ Transcatheter Valve Repair System is associated with a “striking”...

This content is only for readers outside of the US as it discusses a device that is not FDA approved. The PASCAL repair system (Edwards...

TVT 2019: PASCAL system may be beneficial for managing tricuspid regurgitation

New data for the PASCAL system (Edwards Lifesciences), which received the CE mark in February 2019 for the management of mitral regurgitation, suggest it...

TVT 2019: Purpose-designed temporary pacing guidewire has potential to make implantation...

Speaking during an innovation session at TVT 2019 (12-15 June, Chicago, USA), Mark Hensey (Centre for Heart Valve Innovation, St Paul's Hospital, University of...

TVT 2019: TAVI is “preferred therapy” for low-risk patients

This morning at TVT 2019 (12-15 June, Chicago, USA), in separate presentations, the principal investigators of PARTNER 3 and Evolut Low Risk trials both...